Adverse event monitoring of the human papillomavirus vaccines in Scotland

• DOI: 10.1111/imj.13005
• Publication Date: 2016-01-14T03:20:59Z
• Authors: R. L. Cameron; S. Ahmed; K. G. J. Pollock
• Keywords: HPV vaccines

Background Human papillomavirus ( HPV ) vaccines are currently utilised globally in national immunisation programmes. While evidence from clinical trials and epidemiological studies suggest that the both effective safe, concerns about safety of vaccine scientifically unproven associations with severe adverse events following have led to dramatic decreases uptake Japan acceptance issues other countries. Aim In Scotland, we hospital admissions data assess impact programme on incidence 60 diagnoses between 2004 2014 girls boys; boys acting as a comparator group. Methods Tabular graphical outputs number admissions, ratio 59 were created trends before after introduction vaccine. Data linkage was investigate further increase Bell palsy diagnoses. Results Fifty‐four showed no change programme, while small increases observed for palsy, coeliac disease, ovarian dysfunction, juvenile onset type 1 diabetes, demyelinating disease rheumatoid arthritis, none statistically significant. Conclusions Consistent previous evidence, present disaggregate reiterate vaccines.